BG

Bellevue Group Portfolio holdings

AUM $4.81B
1-Year Est. Return 29.28%
This Quarter Est. Return
1 Year Est. Return
+29.28%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.07B
AUM Growth
-$1.54B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
187
New
Increased
Reduced
Closed

Top Buys

1
+$58.1M
2
+$41.4M
3
+$28.1M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$25.4M
5
CLDX icon
Celldex Therapeutics
CLDX
+$24.9M

Top Sells

1
+$98M
2
+$85.7M
3
+$47.7M
4
BMY icon
Bristol-Myers Squibb
BMY
+$46.5M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$42.9M

Sector Composition

1 Healthcare 98.26%
2 Industrials 0.38%
3 Energy 0.03%
4 Communication Services 0.01%
5 Technology 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
151
$343K ﹤0.01%
1,348
152
$314K ﹤0.01%
+969
153
$296K ﹤0.01%
47,000
-1,000
154
$229K ﹤0.01%
+4,100
155
$195K ﹤0.01%
2,100
156
$169K ﹤0.01%
662
157
$160K ﹤0.01%
+5,000
158
$124K ﹤0.01%
808
-310,692
159
$114K ﹤0.01%
1,600
160
$109K ﹤0.01%
18,000
161
$109K ﹤0.01%
1,920
-318,640
162
$108K ﹤0.01%
170
163
$99K ﹤0.01%
1,050
164
$92K ﹤0.01%
1,300
165
$88K ﹤0.01%
+964
166
$86K ﹤0.01%
+503
167
$45K ﹤0.01%
+193
168
$27K ﹤0.01%
135
169
$27K ﹤0.01%
739
170
$26K ﹤0.01%
40
171
$21K ﹤0.01%
1,130
172
$19K ﹤0.01%
+484
173
– –
-2,698
174
– –
-744
175
– –
-43,887
4 5 6
7
8